scholarly journals A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

2007 ◽  
Vol 196 (12) ◽  
pp. 1732-1740 ◽  
Author(s):  
Julie E. Martin ◽  
Theodore C. Pierson ◽  
Sarah Hubka ◽  
Steve Rucker ◽  
Ingelise J. Gordon ◽  
...  
Keyword(s):  
Clinical Trial ◽  
West Nile Virus ◽  
Dna Vaccine ◽  
Phase 1 ◽  
Neutralizing Antibody ◽  
Healthy Adults ◽  
West Nile ◽  
Phase 1 Clinical Trial

scholarly journals A West Nile Virus DNA Vaccine Utilizing a Modified Promoter Induces Neutralizing Antibody in Younger and Older Healthy Adults in a Phase I Clinical Trial

2011 ◽  
Vol 203 (10) ◽  
pp. 1396-1404 ◽  
Author(s):  
Julie E. Ledgerwood ◽  
Theodore C. Pierson ◽  
Sarah A. Hubka ◽  
Niraj Desai ◽  
Steve Rucker ◽  
...  
Keyword(s):  
Clinical Trial ◽  
West Nile Virus ◽  
Phase I ◽  
Dna Vaccine ◽  
Neutralizing Antibody ◽  
Healthy Adults ◽  
Phase I Clinical Trial ◽  
West Nile

scholarly journals Safety and Immunogenicity of a Tetravalent Dengue DNA Vaccine Administered with a Cationic Lipid-Based Adjuvant in a Phase 1 Clinical Trial

2018 ◽  
Vol 98 (3) ◽  
pp. 849-856 ◽  
Author(s):  
Janine R. Danko ◽  
Tadeusz Kochel ◽  
Nimfa Teneza-Mora ◽  
Thomas C. Luke ◽  
Kanakatte Raviprakash ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dna Vaccine ◽  
Phase 1 ◽  
Cationic Lipid ◽  
Phase 1 Clinical Trial

Evaluation of a prototype dengue-1 DNA vaccine in a Phase 1 clinical trial

Vaccine ◽  
2011 ◽  
Vol 29 (5) ◽  
pp. 960-968 ◽  
Author(s):  
Charmagne G. Beckett ◽  
Jeffrey Tjaden ◽  
Timothy Burgess ◽  
Janine R. Danko ◽  
Cindy Tamminga ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dna Vaccine ◽  
Phase 1 ◽  
Phase 1 Clinical Trial

scholarly journals Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

2020 ◽  
pp. 100689
Author(s):  
Pablo Tebas ◽  
ShuPing Yang ◽  
Jean D. Boyer ◽  
Emma L. Reuschel ◽  
Ami Patel ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Dna Vaccine ◽  
Preliminary Report ◽  
Phase 1 ◽  
Open Label ◽  
Phase 1 Clinical Trial ◽  
Open Label Phase

Safety and immunogenicity of a mRNA rabies vaccine in healthy adults: an open-label, non-randomised, prospective, first-in-human phase 1 clinical trial

The Lancet ◽  
2017 ◽  
Vol 390 (10101) ◽  
pp. 1511-1520 ◽  
Author(s):  
Martin Alberer ◽  
Ulrike Gnad-Vogt ◽  
Henoch Sangjoon Hong ◽  
Keyvan Tadjalli Mehr ◽  
Linus Backert ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Phase 1 ◽  
Rabies Vaccine ◽  
Healthy Adults ◽  
Open Label ◽  
Phase 1 Clinical Trial

scholarly journals A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

Vaccine ◽  
2008 ◽  
Vol 26 (50) ◽  
pp. 6338-6343 ◽  
Author(s):  
Julie E. Martin ◽  
Mark K. Louder ◽  
LaSonji A. Holman ◽  
Ingelise J. Gordon ◽  
Mary E. Enama ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Immune Responses ◽  
Phase I ◽  
Dna Vaccine ◽  
Neutralizing Antibody ◽  
Healthy Adults ◽  
Phase I Clinical Trial ◽  
Cellular Immune Responses ◽  
Cellular Immune

A Phase 1 clinical trial of a DNA vaccine for Venezuelan equine encephalitis delivered by intramuscular or intradermal electroporation

Vaccine ◽  
2016 ◽  
Vol 34 (31) ◽  
pp. 3607-3612 ◽  
Author(s):  
Drew Hannaman ◽  
Lesley C. Dupuy ◽  
Barry Ellefsen ◽  
Connie S. Schmaljohn
Keyword(s):  
Clinical Trial ◽  
Dna Vaccine ◽  
Phase 1 ◽  
Venezuelan Equine Encephalitis ◽  
Phase 1 Clinical Trial
Sign in / Sign up

Export Citation Format

Share Document